EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Mednow Inc (MDNWF) fair value: what the stock is really worth

As of Aug 11, 2026: fair value of Mednow Inc $0.03, price $0.02, upside +60.0%, quality 20 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? Yes
  2. Good quality? No
  3. Add to watchlist

Healthcare · US

MI Mednow Inc logo Thin data Sep 24, 2026

Mednow Inc

MDNWF · US

Cheap, value-trap riskThe stock looks deeply undervalued, but low quality raises value-trap risk.

✓Fair value $0.0320 · Strongly undervalued (+60.0%)
!Quality 20/100
!Mixed Growth (revenue YoY +3919.0 %/yr)
!Loss-making · -62.9% net margin (TTM)
!negative free cash flow
!Mixed vs. peers (4/9)
!Narrow moat 3/100
!Evidence only low, so the estimate is less certain
Watch Mednow Inc for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free Pro now: $1 first month

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$2.02 $0.0031 Fair Value $0.0320 Jul 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.

How to read this chart

60‑month range $0.0031 – $2.02 · fair‑value band $0.0280 – $0.0400 · the $0.0200 price screens below the $0.0320 fair value. Dashed = 300-day average. As of Sep 24, 2026.

Follow Mednow in your weekly email

Every Wednesday you see whether Mednow is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Mednow Inc., a healthcare company, develops and operates a proprietary web and mobile application to facilitate the sale and distribution of prescription medications and the delivery of virtual care, telemedicine services, and doctor home visits in Canada.

Show more

Mednow Inc., a healthcare company, develops and operates a proprietary web and mobile application to facilitate the sale and distribution of prescription medications and the delivery of virtual care, telemedicine services, and doctor home visits in Canada. It also owns and operates retail pharmacies under the Mednow Pharmacy name located in the provinces of British Columbia and Ontario. The company was incorporated in 2018 and is headquartered in Vancouver, Canada.

Stock analysis

Mednow Inc (MDNWF) currently trades at $0.0200, while our model-based Fair Value estimate is $0.0320, implying the stock looks roughly 37.5% undervalued today.

Show more

Valuation

How firm this estimate is: it rests on 1 models at a data quality of 80/100, which puts the evidence level at low.

Scenario range: $0.0280 (bear) to $0.0400 (bull), the price of $0.0200 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 20/100 (below-average quality), in the Healthcare sector.

Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.

Mednow Inc reported revenue of $16.6M in FY2022 versus $0 in FY2020. Reported net income was −$29.5M in FY2022.

Key figures

Market cap $517K · EPS (TTM) $−0.8900 · Net margin −62.9% · Return on equity −384% · Return on assets (EBIT) −38.2% · Operating margin −29.7% · Revenue (TTM) $41.6M · Revenue growth (YoY) +105%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 22 out of 100 (low confidence).

What moves the price

The share trades at its 52-week high and at its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at 6% fair-value upside, at 60%, MDNWF screens cheaper than that median.

Fair Value models

Bear $0.0280 Fair Value $0.0320 Bull $0.0400
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
NCAV (Graham) $0.1200 $0.1600 $0.2400 51
All 1 models by family
Asset-Based
NCAV (Graham) $0.1200 $0.1600 $0.2400 51

Open the full fair value analysis →

Notify me when MDNWF reaches fair value

Put MDNWF on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 20/100

Of which business quality 26 · Market factors (momentum, volatility) 45

Profitability 17
Margins and returns on capital today
Quality Growth 75
Are margins and returns improving?
Cashflow 1
Earnings quality: real cash, not paper profit
Fin. Strength 59
Balance sheet, leverage, solvency risk
Investment 5
Disciplined investing over empire-building
Low Volatility 63
Calm price path (market factor)
Momentum 40
Price trend over the last 3–12 months (market factor)
52W Momentum 33
Distance to the 52-week high (market factor)
Net Issuance 0
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 26/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2022 is a loss year, no rate is defined from a loss
not computed

Watch MDNWF, get fair value alerts →

Compare Mednow Inc with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Health Information Services · 128 stocks

Beats the industry median on 4/8 measures
A mixed picture versus its industry peers.
Valuation
Quality Score 26 · Bottom 25%
Fair Value upside +60.0% · Top 25%
Profitability
Return on assets −48.5% · Bottom 25%
Net margin (TTM) −62.9% · Bottom 25%
Operating margin (TTM) −29.7% · Bottom 25%
Growth and dividend
Revenue growth 104.9% · Top 25%

Valuation Multiplesvs Health Information Services median · lower = cheaper

P/B 0.09× · Cheapest 25%
P/S (TTM) 0.01× · Cheapest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)100 · sector 0
FUTURE (revenue growth)100 · sector 41
PAST (return on equity)0 · sector 8
HEALTH (low debt)0 · sector 98
DIVIDEND (yield)0 · sector 44

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Health Information Services stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Veeva Systems Inc VEEV $278.57 $306.43 +10%
Pro Medicus Limited PME A$161.00 A$84.62 −47%
BrightSpring Health Services, Inc BTSG $56.54 $25.86 −54%
Hinge Health, Inc HNGE $95.57 $51.25 −46%
HealthEquity, Inc HQY $88.44 $97.28 +10%
Waystar Holding WAY $24.70 $27.17 +10%
Doximity, Inc DOCS $26.35 $31.41 +19%
XtalPi Holdings 2228 HK$7.75 HK$1.50 −81%
Inventurus Knowledge Solutions Limited IKS ₹1,779 ₹1,883 +6%
Privia Health Group PRVA $19.62 $5.02 −74%

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Calculator with industry benchmark Peter Lynch Fair Value Formula &…Calculator with industry benchmark
Run the numbers yourself: free valuation calculators
DCF CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorFama-French ModelIntrinsic Value
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Mednow Inc · Fair Value
$0.0320 +38%Fair Value
Calculator →

Cite: Fair Value Calculator (2026). "Mednow Inc Fair Value". https://www.fairvalue-calculator.com/stock/MDNWF

Frequently asked questions

Is Mednow Inc (MDNWF) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of $0.0320 versus the last price from Aug 11, 2026 of $0.0200, about +60% upside (undervalued).
What is the fair value of MDNWF?
Our model-based fair value for Mednow Inc is $0.0320 (as of Sep 24, 2026), built from audited fundamentals. Last price (from Aug 11, 2026): $0.0200.
What is the quality score of MDNWF?
Mednow Inc has a Quality Score of 20/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Mednow Inc (MDNWF)?
Our model-based price target is the fair value of $0.0320 (as of Sep 24, 2026) from 1 valuation models. Cautious scenario $0.0280, optimistic scenario $0.0400. It is a calculation from audited fundamentals, not an analyst target.
What is the Mednow Inc stock forecast for 2026?
Our models put fair value at $0.0320, about +60% upside versus the last price from Aug 11, 2026 of $0.0200 (undervalued). Cautious scenario $0.0280, optimistic scenario $0.0400. The calculation is refreshed regularly with new filings.
What is the revenue of Mednow Inc (MDNWF)?
Mednow Inc reported trailing-twelve-month revenue of about $41.6M (latest available figure, as of Sep 24, 2026).
What is the intrinsic value of Mednow Inc (MDNWF)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Mednow Inc it is $0.0320 per share (as of Sep 24, 2026), against a price of $0.0200. It is the blended result of 1 valuation models (cash flow, earnings, asset, dividend).
Is Mednow Inc stock overvalued or undervalued in 2026?
As of Sep 24, 2026, MDNWF trades below its calculated fair value: price $0.0200, fair value $0.0320, a gap of about +60% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of MDNWF?
No. The price is what the market pays today ($0.0200); the fair value is what the company's own numbers justify ($0.0320). For Mednow Inc the two are $0.0120 per share apart. That gap is exactly why we show both numbers side by side.
How much is Mednow Inc worth?
The market values Mednow Inc at about $517K (market capitalisation, as of Sep 24, 2026). Per share that is $0.0200; our models calculate a fair value of $0.0320 per share.
What do the bullish and bearish scenarios say about MDNWF?
Our models span a range for Mednow Inc: cautious scenario $0.0280, base $0.0320, optimistic $0.0400 per share (as of Sep 24, 2026, price $0.0200). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Mednow Inc (MDNWF)?
Balance-sheet figures for Mednow Inc (as of Sep 24, 2026): return on equity −384.3%. They feed the Quality Score of 20/100, which measures business quality independently of the share price.
How far is MDNWF from its 52-week high?
Mednow Inc trades at $0.0200, at its 52-week high of $0.0200 and at the low of $0.0200 (as of Aug 11, 2026). Distance from the high says nothing about value: that is what the fair value of $0.0320 is for.
Which stocks are comparable to Mednow Inc?
From the same area (Healthcare) we also value Veeva Systems Inc, Pro Medicus Limited, BrightSpring Health Services, Inc, Hinge Health, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Mednow Inc stock attractive at the current price?
The data as of Sep 24, 2026: price $0.0200, calculated fair value $0.0320 (+60%), Quality Score 20/100, from 1 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of MDNWF calculated?
We run Mednow Inc through 1 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $0.0320, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. Mednow Inc currently trades 38 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Mednow Inc (MDNWF)?
The latest price we hold is from Aug 11, 2026 and stands at $0.0200. Our model-based fair value is $0.0320, about +60% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Mednow Inc right now?
The large discount to fair value meets weak quality (20/100). That raises the risk this is a value trap rather than a bargain. The price is below even our cautious bear case ($0.0280). The market is more pessimistic than our downside scenario. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.

Key figures of Mednow Inc

How large is the market capitalisation of Mednow Inc (MDNWF)?
The market capitalisation of Mednow Inc is $517K. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What are the earnings per share of Mednow Inc (MDNWF)?
Earnings per share at Mednow Inc are $−0.8900. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Mednow Inc (MDNWF)?
The net margin of Mednow Inc is −62.9% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Mednow Inc (MDNWF)?
The return on equity (ROE) of Mednow Inc is −384% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Mednow Inc (MDNWF)?
On an EBIT basis the return on assets of Mednow Inc is −38.2% (avg 4y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Mednow Inc (MDNWF)?
The operating margin of Mednow Inc is −29.7% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Mednow Inc (MDNWF)?
Revenue at Mednow Inc is growing +105% versus a year earlier. How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Mednow Inc (MDNWF) generate?
The free cash flow of Mednow Inc is −$19.1M (fiscal year 2022). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Mednow Inc (MDNWF) carry?
The net debt of Mednow Inc is $2.0M (fiscal year 2022). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Mednow Inc in the live analysis

One click puts Mednow Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.